India · Delayed Price · Currency is INR OneSource Specialty Pharma Company Description
OneSource Specialty Pharma Limited, a biopharmaceutical company, engages in the research, development, manufacture, and commercialization of biological drug products in various injectable formats in India and internationally.
The company provides end-to-end CDMO services across various phases of preclinical and clinical development and commercial supply of biologics.
It also offers drug-devices, including prefilled syringes, dial and push variable and fixed dose pen injectors, pull push fixed dose pens, and autoinjectors; sterile injectables; soft gelatin capsules; and biologics solutions for microbial and mammalian cell line biopharmaceuticals, cell and gene therapy, and RNA products.
OneSource Specialty Pharma Limited was formerly known as Stelis Biopharma Limited and changed its name to OneSource Specialty Pharma Limited in February 2024.
The company was incorporated in 2007 and is based in Bengaluru, India.
| Country | India |
| Founded | 2007 |
| Industry | Biotechnology |
| Sector | Healthcare |
| Employees | 525 |
| CEO | Neeraj Sharma |
Contact Details
Address: Star 1, Opp IIM Bangalore Bengaluru, Karnataka 560076 India | |
| Phone | 91 80 6784 0738 |
| Website | onesourcecdmo.com |
Stock Details
| Ticker Symbol | ONESOURCE |
| Exchange | National Stock Exchange of India |
| Fiscal Year | April - March |
| Reporting Currency | INR |
| SIC Code | 8731 |
Key Executives
| Name | Position |
|---|---|
| Neeraj Sharma | Chief Executive Officer, MD and Director |
| Trisha A | Company Secretary and Compliance officer |
| Arun Kumar Pillai B.Com. | Founder and Non-Executive Director |
| Anurag Bhagania | Chief Financial Officer |
| Biju Mathew | Chief Operating Officer |
| Dr. Prateek Gupta | Senior Vice President and Head of Technical Development |
| Milan Doshi | Senior Vice President of Global BD |
| Ravi Kumar | Head of Corporate Strategy and Operational Excellence |
| Bernhard Thurnbauer | Chief Quality Officer |